Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Egalet-002 in chronic noncancer pain
NCT02603705Phase 3Completed
- Sponsor
- Egalet
- Start
- Mar 2016
- Primary completion
- Jun 2017
- Countries
- 1
01
Overview
A Phase 3 trial of Egalet-002 in Chronic non-cancer pain (CNCP), sponsored by Egalet. Started Mar 2016; status: completed.
02
Drugs
Egalet-002
03
Conditions
Chronic non-cancer pain (CNCP)
Beyond the preview
Go deeper on NCT02603705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02603705.